Scientific

MK5 Microarray Data

Affected Genes - Ontology Breakdown - Gene Enrichment - Proteome Analysis

These are the micro-array results of a differential gene expression microarray experiments and the subsequent analysis steps performed on them. The up/down- regulation ratio was obtained by measuring WT cells against MK5 activated cells. See material and methods for technical information as well as the data usage policy.

MK5 Proteome Analysis - Divided Values

Type II network, divided values. Interestingly most of the proteins in the first 100 positions in this table would occur in the divided ranks table between position 100 and 200, indicating a difference in emphasis between the two simulations but not in the overall function. The fully annotated table, include Ensembl gene identifiers and network values can be found in the supplementary data.


Navigation/Query Panel:
Click on the attribute name to hide/unhide it. The green arrows can be used to shift columns left/right. Exact word match is written as =..., regular expressions can be matched with ~.... To select all values larger or equal than use >.... This would be <... for values smaller or equal than. To select all values within a specific range use [...,...].
Rank Gene description Value Type Network Comparison Type Interaction Map Filtered red green network_comparison
Results: HTML CSV LaTeX Showing element 2013 to 2062 of 9634 in total 
Value Type: Measured
Network Comparison Type: Divided

\def\wcA{0.125\textwidth}
\def\wcB{0.125\textwidth}
\def\wcC{0.125\textwidth}
\def\wcD{0.125\textwidth}
\def\wcE{0.125\textwidth}
\def\wcF{0.125\textwidth}
\def\wcG{0.125\textwidth}
\begin{longtable}{|c|c|c|c|c|c|c|}
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
Rank\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
description\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Interaction Map\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
Filtered\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
red\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
green\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
network\_comparison\vspace{3pt}}\\
\hline
\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
504\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
g protein pathway suppressor 2 (gps2 protein). [source:swissprot;acc:q13227]\vspace{3pt}}&\multirow{3}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
0\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
537\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
569\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1.05959\vspace{3pt}}\\\cline{2-2}\cline{4-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
protein cgi-100 precursor. [source:swissprot;acc:q9y3a6]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
1\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
9136.68\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
9582.26\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1.04877\vspace{3pt}}\\\cline{1-2}\cline{4-7}
\multirow{3}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
505\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
adenylosuccinate synthase-like 1. [source:refseq;acc:nm\_152328]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
0\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
2027.06\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1913.73\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1.05922\vspace{3pt}}\\\cline{2-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
signal transduction protein cbl-b (sh3-binding protein cbl-b). [source:swissprot;acc:q13191]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
1\vspace{3pt}}}&\parbox{\wcE}{\vspace{3pt}\noindent
6856.71\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
7838.3\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1.14316\vspace{3pt}}\\\cline{2-3}\cline{5-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
solute carrier family 13, member 3 (sodium-dependent high-affinity dicarboxylate transporter 2) (na(+)/dicarboxylate cotransporter 3) (nadc-3) (hnadc3). [source:swissprot;acc:q8wwt9]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}}&&\parbox{\wcE}{\vspace{3pt}\noindent
8890.93\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
9324.41\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1.04876\vspace{3pt}}\\\cline{1-2}\cline{4-7}
\multirow{3}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
506\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
dead-box protein 3, y-chromosomal. [source:swissprot;acc:o15523]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
0\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
2437.08\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
2301.01\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1.05913\vspace{3pt}}\\\cline{2-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
eukaryotic translation initiation factor 6 (eif-6) (b4 integrin interactor) (cab) (p27(bbp)) (b(2)gcn homolog). [source:swissprot;acc:p56537]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\multirow{3}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
1\vspace{3pt}}}&\parbox{\wcE}{\vspace{3pt}\noindent
3893.85\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
4450.98\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1.14308\vspace{3pt}}\\\cline{2-3}\cline{5-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
solute carrier family 13, member 2 (renal sodium/dicarboxylate cotransporter) (na(+)/dicarboxylate cotransporter 1) (nadc-1). [source:swissprot;acc:q13183]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&&\parbox{\wcE}{\vspace{3pt}\noindent
8890.86\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
9324.32\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1.04875\vspace{3pt}}\\\cline{1-3}\cline{5-7}
\multirow{3}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
507\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
cbl e3 ubiquitin protein ligase (ec 6.3.2.-) (signal transduction protein cbl) (proto-oncogene c-cbl). [source:swissprot;acc:p22681]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&&\parbox{\wcE}{\vspace{3pt}\noindent
6875.08\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
7858.38\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1.14302\vspace{3pt}}\\\cline{2-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
pr-domain zinc finger protein 7. [source:swissprot;acc:q9nqw5]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
0\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
825.575\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
779.665\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1.05888\vspace{3pt}}\\\cline{2-2}\cline{4-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
solute carrier family 13, member 4 (na+/sulfate cotransporter sut-1). [source:swissprot;acc:q9ukg4]\vspace{3pt}}&&\multirow{3}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
1\vspace{3pt}}}&\parbox{\wcE}{\vspace{3pt}\noindent
8890.11\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
9323.45\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1.04874\vspace{3pt}}\\\cline{1-3}\cline{5-7}
\multirow{3}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
508\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
1-acyl-sn-glycerol-3-phosphate acyltransferase beta (ec 2.3.1.51) (1- agp acyltransferase 2) (1-agpat 2) (lysophosphatidic acid acyltransferase-beta) (lpaat-beta) (1-acylglycerol-3-phosphate o- acyltransferase 2). [source:swissprot;acc:o15120]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&&\parbox{\wcE}{\vspace{3pt}\noindent
7556.75\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
8636.87\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1.14293\vspace{3pt}}\\\cline{2-3}\cline{5-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
solute carrier family 13, member 1 (renal sodium/sulfate cotransporter) (na(+)/sulfate cotransporter) (hnasi-1). [source:swissprot;acc:q9bzw2]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}}&&\parbox{\wcE}{\vspace{3pt}\noindent
8890.11\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
9323.44\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1.04874\vspace{3pt}}\\\cline{2-2}\cline{4-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
ubiquitin-like protein smt3b (sentrin 2) (hsmt3). [source:swissprot;acc:p55855]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
0\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
2065.68\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1951.18\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1.05868\vspace{3pt}}\\\hline
\multirow{3}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
509\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
1-acyl-sn-glycerol-3-phosphate acyltransferase alpha (ec 2.3.1.51) (1- agp acyltransferase 1) (1-agpat 1) (lysophosphatidic acid acyltransferase-alpha) (lpaat-alpha) (1-acylglycerol-3-phosphate o- acyltransferase 1) (g15 protein). [source:swissprot;acc:q99943]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
1\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
7551.8\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
8630.06\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1.14278\vspace{3pt}}\\\cline{2-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
dna mismatch repair protein mlh1 (mutl protein homolog 1). [source:swissprot;acc:p40692]\vspace{3pt}}&\multirow{4}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
0\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
4881.38\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
4610.93\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1.05865\vspace{3pt}}\\\cline{2-2}\cline{4-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
repressor of estrogen receptor activity; b-cell associated protein. [source:refseq;acc:nm\_007273]\vspace{3pt}}&&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
1\vspace{3pt}}}&\parbox{\wcE}{\vspace{3pt}\noindent
8198.63\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
8598.12\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1.04873\vspace{3pt}}\\\cline{1-2}\cline{5-7}
\multirow{3}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
510\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
dynein intermediate chain 1, cytosolic (dh ic-1) (cytoplasmic dynein intermediate chain 1). [source:swissprot;acc:o14576]\vspace{3pt}}&&&\parbox{\wcE}{\vspace{3pt}\noindent
6995.22\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
7336.04\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1.04872\vspace{3pt}}\\\cline{2-2}\cline{4-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
dyskerin (nucleolar protein nap57) (cbf5 homolog). [source:swissprot;acc:o60832]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
0\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
2680.03\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
2837.1\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1.05861\vspace{3pt}}\\\cline{2-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
growth factor receptor-bound protein 2 (grb2 adapter protein) (sh2/sh3 adapter grb2) (ash protein). [source:swissprot;acc:p29354]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
1\vspace{3pt}}}&\parbox{\wcE}{\vspace{3pt}\noindent
5975.11\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
6826.24\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1.14245\vspace{3pt}}\\\cline{1-3}\cline{5-7}
\multirow{3}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
511\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
large neutral amino acids transporter small subunit 1 (l-type amino acid transporter 1) (4f2 light chain) (4f2 lc) (4f2lc) (cd98 light chain) (integral membrane protein e16) (hlat1). [source:swissprot;acc:q01650]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}}&&\parbox{\wcE}{\vspace{3pt}\noindent
7970.13\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
8357.56\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1.04861\vspace{3pt}}\\\cline{2-2}\cline{4-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
p28 ing5. [source:refseq;acc:nm\_032329]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
0\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
3842.88\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
3631.3\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1.05827\vspace{3pt}}\\\cline{2-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
serine/threonine-protein kinase nek2 (ec 2.7.1.37) (nima-related protein kinase 2) (nima-like protein kinase 1) (hspk 21). [source:swissprot;acc:p51955]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
1\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
5975.11\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
6826.24\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1.14245\vspace{3pt}}\\\hline
\multirow{3}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
512\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
brain protein 16. [source:refseq;acc:nm\_016458]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
0\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
3002.7\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
2837.61\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1.05818\vspace{3pt}}\\\cline{2-2}\cline{4-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
heterogeneous nuclear ribonucleoprotein f (hnrnp f). [source:swissprot;acc:p52597]\vspace{3pt}}&&\multirow{3}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
1\vspace{3pt}}}&\parbox{\wcE}{\vspace{3pt}\noindent
7260.72\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
7613.31\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1.04856\vspace{3pt}}\\\cline{2-3}\cline{5-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
small glutamine rich protein with tetratricopeptide repeats 2. [source:refseq;acc:nm\_019072]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}}&&\parbox{\wcE}{\vspace{3pt}\noindent
10807.4\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
12338.5\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1.14167\vspace{3pt}}\\\cline{1-2}\cline{5-7}
\multirow{3}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
513\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
1-acyl-sn-glycerol-3-phosphate acyltransferase gamma (ec 2.3.1.51) (1- agp acyltransferase 3) (1-agpat 3) (lysophosphatidic acid acyltransferase-gamma) (lpaat-gamma) (1-acylglycerol-3-phosphate o- acyltransferase 3). [source:swissprot;acc:q9nrz7]\vspace{3pt}}&&&\parbox{\wcE}{\vspace{3pt}\noindent
7485.08\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
8543.66\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1.14143\vspace{3pt}}\\\cline{2-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
40s ribosomal protein s10. [source:swissprot;acc:p46783]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
0\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1201.47\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1135.73\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1.05788\vspace{3pt}}\\\cline{2-2}\cline{4-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
pyrroline 5-carboxylate reductase isoform. [source:refseq;acc:nm\_013328]\vspace{3pt}}&&\multirow{3}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
1\vspace{3pt}}}&\parbox{\wcE}{\vspace{3pt}\noindent
8458.7\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
8868.63\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1.04846\vspace{3pt}}\\\cline{1-3}\cline{5-7}
\multirow{3}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
514\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
1-acyl-sn-glycerol-3-phosphate acyltransferase delta (ec 2.3.1.51) (1- agp acyltransferase 4) (1-agpat 4) (lysophosphatidic acid acyltransferase-delta) (lpaat-delta) (1-acylglycerol-3-phosphate o- acyltransferase 4). [source:swissprot;acc:q9nrz5]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&&\parbox{\wcE}{\vspace{3pt}\noindent
7477\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
8532.02\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1.1411\vspace{3pt}}\\\cline{2-3}\cline{5-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
disks large-associated protein 3 (dap-3) (sap90/psd-95-associated protein 3) (sapap3) (psd-95/sap90 binding protein 3) (fragment). [source:swissprot;acc:o95886]\vspace{3pt}}&\multirow{4}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}}&&\parbox{\wcE}{\vspace{3pt}\noindent
7104.55\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
6776.72\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1.04838\vspace{3pt}}\\\cline{2-2}\cline{4-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
rho gdp-dissociation inhibitor 1 (rho gdi 1) (rho-gdi alpha). [source:swissprot;acc:p52565]\vspace{3pt}}&&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
0\vspace{3pt}}}&\parbox{\wcE}{\vspace{3pt}\noindent
17235.5\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
16295.1\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1.05771\vspace{3pt}}\\\cline{1-2}\cline{5-7}
\multirow{3}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
515\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
ba371l19.2 (novel protein similar to 40s ribosomal protein s10 (rps10)). [source:sptrembl;acc:q9nq39]\vspace{3pt}}&&&\parbox{\wcE}{\vspace{3pt}\noindent
1199.57\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1134.29\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1.05755\vspace{3pt}}\\\cline{2-2}\cline{4-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
pyrroline-5-carboxylate reductase (ec 1.5.1.2) (p5cr) (p5c reductase). [source:swissprot;acc:p32322]\vspace{3pt}}&&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
1\vspace{3pt}}}&\parbox{\wcE}{\vspace{3pt}\noindent
8455.54\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
8864.47\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1.04836\vspace{3pt}}\\\cline{2-3}\cline{5-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
transcription factor dp-1 (e2f dimerization partner 1) (drtf1- polypeptide-1) (drtf1). [source:swissprot;acc:q14186]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&&\parbox{\wcE}{\vspace{3pt}\noindent
3890.53\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
4439.07\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1.14099\vspace{3pt}}\\\hline
\multirow{3}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
516\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
60s ribosomal protein l18a. [source:swissprot;acc:q02543]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
0\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
3708.61\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
3920.97\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1.05726\vspace{3pt}}\\\cline{2-2}\cline{4-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
f-actin capping protein alpha-1 subunit (capz alpha-1). [source:swissprot;acc:p52907]\vspace{3pt}}&&\multirow{4}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
1\vspace{3pt}}}&\parbox{\wcE}{\vspace{3pt}\noindent
7450.95\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
7810.66\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1.04828\vspace{3pt}}\\\cline{2-3}\cline{5-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
n-acetylgalactosamine kinase (ec 2.7.1.-) (galnac kinase) (galactokinase 2). [source:swissprot;acc:q01415]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&&\parbox{\wcE}{\vspace{3pt}\noindent
4910.6\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
5600.61\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1.14051\vspace{3pt}}\\\cline{1-3}\cline{5-7}
\multirow{3}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
517\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
dynein intermediate chain 2, cytosolic (dh ic-2) (cytoplasmic dynein intermediate chain 2). [source:swissprot;acc:q13409]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&&\parbox{\wcE}{\vspace{3pt}\noindent
7011.57\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
7349.22\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1.04816\vspace{3pt}}\\\cline{2-3}\cline{5-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
galactose-1-phosphate uridylyltransferase (ec 2.7.7.12) (gal-1-p uridylyltransferase) (udp-glucose--hexose-1-phosphate uridylyltransferase). [source:swissprot;acc:p07902]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&&\parbox{\wcE}{\vspace{3pt}\noindent
4910.6\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
5600.61\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1.14051\vspace{3pt}}\\\cline{2-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
transcription factor-like protein morf4 (mortality factor 4) (cellular senescence-related protein 1) (sen1). [source:swissprot;acc:q9y690]\vspace{3pt}}&\multirow{3}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
0\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1385.47\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1311.25\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1.0566\vspace{3pt}}\\\cline{1-2}\cline{4-7}
\multirow{3}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
518\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
conserved oligomeric golgi complex subunit 5 (13s golgi transport complex 90 kda subunit) (gtc-90) (golgi transport complex 1). [source:swissprot;acc:q9up83]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
1\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
7322.99\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
7675.44\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1.04813\vspace{3pt}}\\\cline{2-2}\cline{4-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
cytochrome c oxidase subunit viia-l related protein, mitochondrial precursor. [source:swissprot;acc:o60397]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
0\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1351.4\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1279.26\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1.05639\vspace{3pt}}\\\cline{2-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
udp-glucose 4-epimerase (ec 5.1.3.2) (galactowaldenase) (udp- galactose 4-epimerase). [source:swissprot;acc:q14376]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\multirow{3}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
1\vspace{3pt}}}&\parbox{\wcE}{\vspace{3pt}\noindent
4910.6\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
5600.61\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1.14051\vspace{3pt}}\\\cline{1-3}\cline{5-7}
\multirow{3}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
519\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
dna repair protein rad51 homolog 1 (hrad51) (hsrad51). [source:swissprot;acc:q06609]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&&\parbox{\wcE}{\vspace{3pt}\noindent
8064.19\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
8452.01\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1.04809\vspace{3pt}}\\\cline{2-3}\cline{5-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
glycogen [starch] synthase, muscle (ec 2.4.1.11). [source:swissprot;acc:p13807]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&&\parbox{\wcE}{\vspace{3pt}\noindent
9648.27\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
10994.9\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1.13957\vspace{3pt}}\\\cline{2-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
keratin associated protein 9.2. [source:refseq;acc:nm\_031961]\vspace{3pt}}&\multirow{3}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
0\vspace{3pt}}}&\parbox{\wcE}{\vspace{3pt}\noindent
1011.61\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
958.097\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcG}{\vspace{3pt}\noindent
1.05585\vspace{3pt}}}\\\cline{1-2}\cline{5-6}
\multirow{3}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
520\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
dipeptidyl peptidase 8 isoform 2; dipeptidyl peptidase 8. [source:refseq;acc:nm\_017743]\vspace{3pt}}&&&\parbox{\wcE}{\vspace{3pt}\noindent
380.866\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
402.138\vspace{3pt}}&\\\cline{2-2}\cline{4-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
disks large-associated protein 2 (dap-2) (sap90/psd-95-associated protein 2) (sapap2) (psd-95/sap90 binding protein 2) (fragment). [source:swissprot;acc:q9p1a6]\vspace{3pt}}&&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
1\vspace{3pt}}}&\parbox{\wcE}{\vspace{3pt}\noindent
7107.45\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
6781.51\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1.04806\vspace{3pt}}\\\cline{2-3}\cline{5-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
endo-beta-n-acetylglucosaminidase. [source:refseq;acc:nm\_022759]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&&\parbox{\wcE}{\vspace{3pt}\noindent
9642.22\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
10986.4\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1.13941\vspace{3pt}}\\\hline
nd{longtable}

Legend:
- Rank is the rank after comparing the two networks

 - Gene is the ensembl human gene identifier measured by 1 or more probes on the microarray

 - Value Type describes how the microarray measurement was processed. Ranked indicates that we sorted all measurements and use the rank as red and green value. Measured is the normal measurement. Squared and Rooted are the square and square root respecitcely. This might be valueable to compensate for non linear light distributions.

 - Network Comparison Type describes whether we divided the red and green types or whether we sutractcted them

 - Interaction Map specifies whether we used only the hig hconfidence protein-protein interactions or also included the low confidence interactions.

 - Filtered specifies whether we only included the high confidence microarry measurements or not.
- http://analysis.yellowcouch.org/